semaglutide fda changes Approval vs Compounded Alternatives What Patients Need to Know

We wrote a medical journal article on this topic, and in the process of writing the article we scoured the medical literature

Symptoms of Glutathione Deficiency Glutathione deficiency is classified as mild, moderate, or severe

Dietitians offer continuous support, monitoring your progress and making necessary adjustments to your meal plan

According to the Summary of Product Characteristics (SmPCs), GLP-1 medications commonly cause nausea (reported in approximately 20-40% of patients with semaglutide and 12-21% with dulaglutide), vomiting, and diarrhoea, particularly during initial treatment and dose escalation

Approval of the higher dose was based on the findings of the STEP UP clinical trial, results of which were published in November 2025